A phase I trial of AM 831 in healthy volunteers.

Trial Profile

A phase I trial of AM 831 in healthy volunteers.

Discontinued
Phase of Trial: Phase I

Latest Information Update: 13 Jul 2012

At a glance

  • Drugs AM 831 (Primary)
  • Indications Schizophrenia
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 13 Jul 2012 Status changed from recruiting to discontinued, as reported by ACADIA Pharmaceuticals in its Form 8-K (filed 13 July 2012).
    • 09 Nov 2011 Status changed from not yet recruiting to recruiting.
    • 07 Nov 2011 The US FDA approved the IND application for this study.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top